Medical Countermeasures New Insights Into Tularemia Pathogen May Inform Next-Generation Medical CountermeasuresGlobal Biodefense StaffMay 14, 2026
Research Scientists Identify Exact Trigger Behind Rare COVID Vaccine Blood ClotsGlobal Biodefense StaffFebruary 15, 2026
Infectious Diseases Last Flu Season Saw Highest U.S. Hospitalization Rates in Over a DecadeGlobal Biodefense StaffSeptember 24, 2025
New Study Reveals Key to Marburg and Ebola Virus Assembly, Opening Door to Broad-Spectrum Antivirals Pathogens September 23, 2025 …
New Sensor Design Offers Ultra-Sensitive Detection Using Nanomaterials Biodetection September 4, 2025 …
New Test Enhances Botulism Detection in Food for Public Health and Biodefense Biodetection July 14, 2025 …
Unlocking a New Target Against Crimean-Congo Hemorrhagic Fever Virus Medical Countermeasures July 3, 2025 …
Study Reveals Potential for Sexual Transmission of Lassa Virus in Natural Rodent Reservoirs Pathogens June 26, 2025 …
High Stakes in Sichuan: A Decade of Deadly H5N6 Infections Raises Urgency for Avian Influenza Control Pathogens June 9, 2025 …
Single-Dose VSV Vaccine Fully Protects Mice Against Crimean-Congo Hemorrhagic Fever Medical Countermeasures June 5, 2025 …
Forging Regional Resilience: Latin America’s Unified Strategy for Future Pandemics Preparedness May 5, 2025 …
Innovative VLP-Based Vaccine Shows Promise Against Avian Influenza Medical Countermeasures April 30, 2025 …
Federal Scientists Use AI to Optimize Antibodies Against Mutations Medical Countermeasures April 7, 2025 …
New Virus Characterization Center Will Conduct Sweeping Study of Human Viruses Research January 23, 2025 …
Lassa Fever Vaccine Study Supports Advancement to Phase I Trial Medical Countermeasures August 14, 2024 …
